Panel Discussion | Disparities in Interventional Cardiology - Gender, Age, Hispanics, Veterans, and Around the World

Saturday, March 7, 2026

11:51 AM - 12:15 PM EST

Location: Cabinet

Moderator(s)

Sara D. Collins, MD

Medical Director
Flourish Research Bowie
Bowie, Maryland, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly & Company: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)
Ernest Spitzer, MD

Chief Executive Officer
Cardialysis B.V.
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biosensors Europe: Grant/Research Support (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Medtronic Inc: Grant/Research Support (Ongoing); Novo Nordisk A/S: Grant/Research Support (Ongoing); Philips Medical: Grant/Research Support (Ongoing); Pie Medical Imaging: Grant/Research Support (Ongoing); Siemens Healthineers AG: Grant/Research Support (Ongoing)

Panel Discussant(s)

James C. Blankenship, MD MHCM MSCAI MACC

Director of Cardiology, University of New Mexico
University of New Mexico
Albuquerque, New Mexico, United States

Disclosure(s): No financial relationships to disclose
Rachel M. Bond, MD

System Director, Women's Heart Health
Dignity Health, Arizona

Disclosure(s): No financial relationships to disclose
Farshad Forouzandeh, MD, PhD

Associate Professor of Medicine, Interventional Cardiologist
Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Ankur Kalra, MD

Division Chief of Cardiology
State University of New York (SUNY) Upstate Medical Center University, New York, United States

Disclosure(s): No financial relationships to disclose
Andrew J. Klein, MD

Interventional Cardiology, Vascular and Endovascular Medicine
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure(s): No financial relationships to disclose
Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, FHEA, QDip, PGDip, MSc, FESC

Interventional Cardiology Consultant
Bart Heart Centre, St. Bartholomew's Hospital
London, England, United Kingdom

Disclosure(s): No financial relationships to disclose
Madhur A. Roberts, MD

Interventional Cardiology/Faculty Assistant Professor
Tulane University Medical Group, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Sara D. Collins, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly & Company: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)

Ernest Spitzer, MD: Abbott Vascular: Grant/Research Support (Ongoing); Biosensors Europe: Grant/Research Support (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Medtronic Inc: Grant/Research Support (Ongoing); Novo Nordisk A/S: Grant/Research Support (Ongoing); Philips Medical: Grant/Research Support (Ongoing); Pie Medical Imaging: Grant/Research Support (Ongoing); Siemens Healthineers AG: Grant/Research Support (Ongoing)

James C. Blankenship, MD MHCM MSCAI MACC: No financial relationships to disclose

Rachel M. Bond, MD: No financial relationships to disclose

Farshad Forouzandeh, MD, PhD: No financial relationships to disclose

Ankur Kalra, MD: No financial relationships to disclose

Andrew J. Klein, MD: No financial relationships to disclose

Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, FHEA, QDip, PGDip, MSc, FESC: No financial relationships to disclose

Madhur A. Roberts, MD: No financial relationships to disclose